Lauric acid

Lauric acid
Product Name Lauric acid
CAS No.: 143-07-7
Catalog No.: CFN90493
Molecular Formula: C12H24O2
Molecular Weight: 200.31 g/mol
Purity: >=98%
Type of Compound: Miscellaneous
Physical Desc.: Powder
Targets: IL Receptor | TNF-α | NF-kB | ROS | MAPK
Source: The leaves of Trachycarpus fortunei
Solvent: Chloroform, Dichloromethane, Ethyl Acetate, DMSO, Acetone, etc.
Price: $30/20mg
Lauric acid is a middle chain-free fatty acid with strong bactericidal properties. The EC50s for P. acnes, S.aureus, S. epidermidis, are 2, 6, 4 μg/mL, respectively. Lauric acid displays preferential antineoplastic property, including induction of apoptosis in a CRC cell line.
Inquire / Order: manager@chemfaces.com
Technical Inquiries: service@chemfaces.com
Tel: +86-27-84237783
Fax: +86-27-84254680

Address:
1 Building, No. 83, CheCheng Rd., Wuhan Economic and Technological Development Zone, Wuhan, Hubei 430056, PRC
Providing storage is as stated on the product vial and the vial is kept tightly sealed, the product can be stored for up to 24 months(2-8C).

Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20C. Generally, these will be useable for up to two weeks. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.

Need more advice on solubility, usage and handling? Please email to: service@chemfaces.com

The packaging of the product may have turned upside down during transportation, resulting in the natural compounds adhering to the neck or cap of the vial. take the vial out of its packaging and gently shake to let the compounds fall to the bottom of the vial. for liquid products, centrifuge at 200-500 RPM to gather the liquid at the bottom of the vial. try to avoid loss or contamination during handling.
  • J Cell Physiol.2020, 10.1002
  • Curr Eye Res.2018, 43(1):27-34
  • J.Pharm. & Biome. Anal.2023, 2: 100018.
  • Int J Mol Sci.2019, 20(11):E2734
  • Molecules.2019, 24(6):E1155
  • Molecules.2017, 22(12)
  • FEBS Lett.2021, 595(20):2608-2615.
  • Acta Pharmaceutica Hungarica2016, 86:35-40
  • Emirates Journal of Food and Agriculture.2022, 34(6): 528-536.
  • Int J Mol Sci.2020, 21(9):3392.
  • Glycerol 1-(26-hydroxyhexacosanoate)

    Catalog No: CFN99835
    CAS No: 177602-14-1
    Price: Inquiry(manager@chemfaces.com)
    Dipalmitin

    Catalog No: CFN90057
    CAS No: 26657-95-4
    Price: Inquiry(manager@chemfaces.com)
    Glycerine trioleate

    Catalog No: CFN90141
    CAS No: 122-32-7
    Price: $30/20mg
    Arachidonic acid

    Catalog No: CFN90058
    CAS No: 506-32-1
    Price: $80/20mg
    Lauric acid

    Catalog No: CFN90493
    CAS No: 143-07-7
    Price: $30/20mg
    Palmitic acid

    Catalog No: CFN99716
    CAS No: 57-10-3
    Price: $30/20mg
    Tricosanoic acid

    Catalog No: CFN98571
    CAS No: 2433-96-7
    Price: $30/20mg
    Octacosanoic Acid

    Catalog No: CFN98572
    CAS No: 506-48-9
    Price: $40/20mg
    Stearic Acid

    Catalog No: CFN93165
    CAS No: 57-11-4
    Price: $30/20mg
    Linoleic acid

    Catalog No: CFN93168
    CAS No: 60-33-3
    Price: $30/20mg
    J Exp Bot. 2014 Jan;65(1):131-41.
    Lauric acid in crown daisy root exudate potently regulates root-knot nematode chemotaxis and disrupts Mi-flp-18 expression to block infection.[Pubmed: 24170741]
    Tomato (Solanum lycopersicum) crops can be severely damaged due to parasitism by the root-knot nematode (RKN) Meloidogyne incognita, but are protected when intercropped with crown daisy (Chrysanthemum coronarium L.). Root exudate may be the determining factor for this protection.
    METHODS AND RESULTS:
    An experiment using pots linked by a tube and Petri dish experiments were undertaken to confirm that tomato-crown daisy intercropping root exudate decreased the number of nematodes and alleviated nematode damage, and to determine crown daisy root exudate-regulated nematode chemotaxis. Following a gas chromatography-mass spectrometry assay, it was found that the intercropping protection was derived from the potent bioactivity of a specific root exudate component of crown daisy, namely Lauric acid. The Mi-flp-18 gene, encoding an FMRFamide-like peptide neuromodulator, regulated nematode chemotaxis and infection by RNA interference. Moreover, it was shown that Lauric acid acts as both a lethal trap and a repellent for M. incognita by specifically regulating Mi-flp-18 expression in a concentration-dependent manner. Low concentrations of Lauric acid (0.5-2.0mM) attract M. incognita and consequently cause death, while high concentrations (4.0mM) repel M. incognita. This study elucidates how Lauric acid in crown daisy root exudate regulates nematode chemotaxis and disrupts Mi-flp-18 expression to alleviate nematode damage, and presents a general methodology for studying signalling systems affected by plant root exudates in the rhizosphere.
    CONCLUSIONS:
    This could lead to the development of economical and feasible strategies for controlling plant-parasitic nematodes, and provide an alternative to the use of pesticides in farming systems.
    J Dermatol Sci. 2014 Mar;73(3):232-40.
    Anti-bacterial and anti-inflammatory properties of capric acid against Propionibacterium acnes: a comparative study with lauric acid.[Pubmed: 24284257]
    Propionibacterium acnes (P. acnes) is a commensal bacterium which is possibly involved in acne inflammation. The saturated fatty acid, Lauric acid (C12:0) has been shown to possess antibacterial and anti-inflammatory properties against P. acnes. Little is known concerning the potential effects of its decanoic counterpart, capric acid (C10:0). To examine the antibacterial and anti-inflammatory activities of capric acid against P. acnes and to investigate the mechanism of the anti-inflammatory action.
    METHODS AND RESULTS:
    The antimicrobial activity of fatty acids was detected using the broth dilution method. An evaluation of P. acnes-induced ear edema in mice was conducted to evaluate the in vivo anti-inflammatory effect. To elucidate the in vitro anti-inflammatory effect, human SZ95 sebocytes and monocytic THP-1 cells were treated with P. acnes alone or in the presence of a fatty acid. The mRNA levels and secretion of pro-inflammatory cytokines were measured by qRT-PCR and enzyme immunoassay, respectively. NF-κB activation and MAPK expression were analyzed by ELISA and Western blot, respectively. Lauric acid had stronger antimicrobial activity against P. acnes than capric acid in vitro and in vivo. However, both fatty acids attenuated P. acnes-induced ear swelling in mice along with microabscess and significantly reduced interleukin (IL)-6 and CXCL8 (also known as IL-8) production in P. acnes-stimulated SZ95 sebocytes. P. acnes-induced mRNA levels and secretion of IL-8 and TNF-α in THP-1 cells were suppressed by both fatty acids, which inhibited NF-κB activation and the phosphorylation of MAP kinases.
    CONCLUSIONS:
    Our data demonstrate that both capric acid and Lauric acid exert bactericidal and anti-inflammatory activities against P. acnes. The anti-inflammatory effect may partially occur through the inhibition of NF-κB activation and the phosphorylation of MAP kinases.
    Chemotherapy. 2013;59(3):214-24.
    Induction of apoptosis by the medium-chain length fatty acid lauric acid in colon cancer cells due to induction of oxidative stress.[Pubmed: 24356281]
    Fatty acids are classified as short-chain (SCFA), medium-chain (MCFA) or long-chain and hold promise as adjunctive chemotherapeutic agents for the treatment of colorectal cancer. The antineoplastic potential of MCFA remains underexplored; accordingly, we compared the MCFA Lauric acid (C12:0) to the SCFA butyrate (C4:0) in terms of their capacity to induce apoptosis, modify glutathione (GSH) levels, generate reactive oxygen species (ROS), and modify phases of the cell cycle in Caco-2 and IEC-6 intestinal cell lines.
    METHODS AND RESULTS:
    Caco-2 and IEC-6 cells were treated with Lauric acid, butyrate, or vehicle controls. Apoptosis, ROS, and cell cycle analysis were determined by flow cytometry. GSH availability was assessed by enzymology. Lauric acid induced apoptosis in Caco-2 (p < 0.05) and IEC-6 cells (p < 0.05) compared to butyrate. In Caco-2 cells, Lauric acid reduced GSH availability and generated ROS compared to butyrate (p < 0.05). Lauric acid reduced Caco-2 and IEC-6 cells in G0/G1and arrested cells in the S and G2/M phases. Lauric acid induced apoptosis in IEC-6 cells compared to butyrate (p < 0.05). Butyrate protected IEC-6 cells from ROS-induced damage, whereas Lauric acid induced high levels of ROS compared to butyrate.
    CONCLUSIONS:
    Compared to butyrate, Lauric acid displayed preferential antineoplastic properties, including induction of apoptosis in a CRC cell line.
    Decursitin D

    Catalog No: CFN95002
    CAS No: 245446-61-1
    Price: $388/5mg
    Glucoliquiritin

    Catalog No: CFN95011
    CAS No: 93446-18-5
    Price: $318/10mg
    Epimedin K

    Catalog No: CFN95019
    CAS No: 174286-13-6
    Price: $288/5mg
    Selaginellin

    Catalog No: CFN95030
    CAS No: 941269-84-7
    Price: $338/5mg
    N-Methylcorydalmine

    Catalog No: CFN95204
    CAS No: 81010-29-9
    Price: $398/5mg
    Isoeuphorbetin

    Catalog No: CFN95207
    CAS No: 50677-55-9
    Price: $318/5mg
    Bidenoside C

    Catalog No: CFN95266
    CAS No: 700877-55-0
    Price: $318/5mg
    3',4',5',5,7-Pentamethoxyflavanone

    Catalog No: CFN95414
    CAS No: 479672-30-5
    Price: $218/20mg
    Oxytroflavoside B

    Catalog No: CFN95490
    CAS No: 1391144-81-2
    Price: $318/10mg
    Catechin 7-O-beta-D-glucopyranoside

    Catalog No: CFN95524
    CAS No: 65597-47-9
    Price: $338/20mg